Edgar Snyder & Associates®
A Law Firm Representing Injured People
Call Us Toll Free 24/7
Published on Feb 01, 2005 by Edgar Snyder

Ban Celebrex, Says Consumer Group


Pfizer Inc., maker of the arthritis painkiller Celebrex, has acknowledged that a 1999 study found Alzheimer's patients using Celebrex to be up to four times more likely to exhibit cardiovascular risk factors than those taking a placebo. In response, the consumer group Public Citizen has renewed it efforts to convince the government to ban Celebrex as well as Bextra, Pfizer's other Cox-2 inhibitor drug. Another drug in that family was Vioxx, which Merck & Co. withdrew from the market in September after studies showed it doubled the risk of heart attack or stroke.

The Food and Drug Adminstration (FDA) has suggested that doctors consider prescribing alternatives, but as yet, Celebrex and Bextra remain on the market. The FDA will hold a hearing this month on the safety of Cox-2 inhibitors.

Source: The PittsburghChannel.com: "New data prompts renewed call for Celebrex ban." Posted 2/1/05.
Think you have a case?
Think you have a case?
Free Case Review
First Name
Last Name
Briefly describe your injuries

Recent News

Sep 16, 2016
Fall and Winter Car Kit
Sep 16, 2016
A New Law May Be Coming for Drivers
Sep 16, 2016
Smartphone Apps for Drivers
Sep 16, 2016
New CDC Tool Will Help Keep Traveling Workers Safe
Sep 14, 2016
PA Residents: You're This Much More Likely to Hit a Deer